TrademarkDir
ETHALAS
DEAD

Serial Number

85837448

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Jan 31, 2013

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

ETHALAS Trademark

Serial Number: 85837448

ETHALAS is a trademark filed by NOVARTIS AG on January 31, 2013. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NOVARTIS AG (7,166 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

January 31, 2013

Registration Date

Not Registered

Published for Opposition

June 25, 2013

Goods & Services

Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Sep 26, 2016 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Sep 26, 2016 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 1, 2016 EXRA
SOU EXTENSION 5 GRANTED
Feb 29, 2016 EX5G
SOU EXTENSION 5 FILED
Feb 18, 2016 EXT5
SOU TEAS EXTENSION RECEIVED
Feb 18, 2016 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 25, 2015 EXRA
SOU EXTENSION 4 GRANTED
Aug 24, 2015 EX4G
SOU EXTENSION 4 FILED
Aug 17, 2015 EXT4
SOU TEAS EXTENSION RECEIVED
Aug 17, 2015 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 25, 2015 EXRA
SOU EXTENSION 3 GRANTED
Feb 24, 2015 EX3G
SOU TEAS EXTENSION RECEIVED
Feb 15, 2015 EEXT
SOU EXTENSION 3 FILED
Jan 15, 2015 EXT3
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 9, 2014 EXRA
SOU EXTENSION 2 GRANTED
Sep 6, 2014 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 5, 2014 AITU
SOU EXTENSION 2 FILED
Aug 17, 2014 EXT2
SOU TEAS EXTENSION RECEIVED
Aug 17, 2014 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 18, 2014 EXRA
SOU EXTENSION 1 GRANTED
Feb 15, 2014 EX1G
SOU EXTENSION 1 FILED
Feb 15, 2014 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 15, 2014 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 20, 2013 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 25, 2013 NPUB
PUBLISHED FOR OPPOSITION
Jun 25, 2013 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 5, 2013 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 22, 2013 CNSA
ASSIGNED TO EXAMINER
May 15, 2013 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 6, 2013 NWOS
NEW APPLICATION ENTERED
Feb 4, 2013 NWAP

Related Trademarks

More from this Owner

BEXJUXI

BEXJUXI

VOBYXA

VOBYXA

VISANSTA

VISANSTA

VISANSTA

VISANSTA

VOBYXA

VOBYXA

CALIHE

CALIHE